Work

Supplementary Figure 8 from PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells

Year: 2026

Type: supplementary-materials

Abstract: Loss of PKCδ in myeloid cells delays tumor growth and is further delayed with anti-PD-L1 therapy in multiple Prkcdfl/fl founders.

DOI: 10.1158/2326-6066.32703197

Authors: Kyle R. Cron, Ayelet Sivan, Keston Aquino-Michaels, Andrea Ziblat, Emily F. Higgs, Randy F. Sweis, Ruxandra Tonea, Seoho Lee, Thomas F. Gajewski

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165013290

Cites:

Cited by:

Related to: